3 unknown, 2 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Unknown 3, Completed 2 |
Follow Hormone Receptor Positive Malignant Neoplasm of Breast: new trials by email Literature Review of Hormone Receptor Positive Malignant Neoplasm of Breast trials Research Report on Hormone Receptor Positive Malignant Neoplasm of Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer Pyrotinib, Trastuzumab, Aromatase Inhibitors - Breast Cancer Female, HER2-positive Breast Cancer | Phase 2 | Unknown | Fuzhou General Hospital | 77 | 2019-11-01 | 2019-09-12 |
| Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC Pyrotinib, Trastuzumab, Aromatase inhibitor - Breast Cancer Female, HER2-positive Breast Cancer | Phase 2 | Unknown | Peking Union Medical College Hospital | 250 | 2019-06-01 | 2019-04-10 |
| Palbociclib in Combination With Tamoxifen as First Line Therapy for Metastatic Hormone Receptor Positive Breast Cancer Palbociclib, Tamoxifen - Hormone Receptor Positive Malignant Neoplasm of Breast, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Phase 2 | Completed | Oana Danciu, MD | 49 | 2017-02-01 | 2026-01-20 |
| Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer Metformin, Placebo - Hormone Receptor Positive Malignant Neoplasm of Breast | Phase 2 | Completed | Seoul National University Hospital | 208 | 2012-05-01 | 2018-09-10 |
| Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer Exemestane, Everolimus - Hormone Receptor Positive Malignant Neoplasm of Breast | Phase 2 | Unknown | Organisation for Oncology and Translational Research | 35 | 2014-01-01 |
Breast Neoplasms (3) · Breast Diseases (2)
Neoplasms (3) · Neoplasms by Site (3) · Skin Diseases (3) · Skin and Connective Tissue Diseases (3) · Breast Diseases (1)
exemestane (3) · Anastrozole (2) · Aromatase Inhibitors (2) · Drug Evaluation (2) · Letrozole (2) · Trastuzumab (2) · pyrotinib (2) · Everolimus (1) · Metformin (1) · Tamoxifen (1) · palbociclib (1)
Fuzhou General Hospital (1) · Oana Danciu, MD (1) · Organisation for Oncology and Translational Research (1) · Peking Union Medical College Hospital (1) · Seoul National University Hospital (1)
China (2) · South Korea (1) · United States (1)
Chen Xi, PhD (1) · Louis Chow (1) · Oana Danciu, M.D. (1) · Qiang Sun, M.D. (1) · Wonshik Han, MD PhD (1)